Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Rheumatol Int. 2018 Sep;38(9):1679-1689. doi: 10.1007/s00296-018-4095-0. Epub 2018 Jul 4.
Rheumatoid arthritis (RA) patients often have altered body composition including reduced muscle mass and increased fat mass. Some RA patients are likely to increase visceral fat without obesity [Body Mass Index (BMI) ≥ 25]. The objective of the study was to determine the association between obesity and/or visceral adiposity and the risk for atherosclerosis in Japanese RA patients. Obesity was evaluated using the BMI, with visceral adiposity evaluated using the visceral fat area (VFA) and the visceral/subcutaneous fat ratio (V/S ratio), quantified using the dual bioelectrical impedance method. Atherosclerosis was evaluated based on the intima-media thickness (IMT) and Plaque score (PS) of the carotid artery, measured using ultrasonography. Multivariate analysis was performed to determine the factors associated with IMT and PS. IMT and PS were compared among groups of patients sub-classified according to BMI and VFA levels. The V/S ratio was higher in RA patients than healthy controls, after adjustment for age, BMI, and waist circumference. On multivariate analysis, the V/S ratio, but not the BMI, was independently associated with the IMT and PS. Among the sub-classifications for BMI and VFA, non-obese patients with a high visceral adiposity (18.5 ≤ BMI < 25 kg/m and VFA ≥ 100 cm) had the highest IMT (mean IMT, 0.93 ± 0.29 mm; maximum IMT, 1.44 ± 0.71 mm) and PS (1.43 ± 0.61), compared to all other BMI and VFA subgroups. RA patients have increased visceral adiposity, which is associated with a high prevalence of atherosclerotic of plaques. Non-obese RA patients who have visceral adiposity have a specifically higher risk for atherosclerosis.
类风湿关节炎(RA)患者常存在身体成分改变,包括肌肉量减少和脂肪量增加。一些 RA 患者可能会在不肥胖(BMI≥25)的情况下增加内脏脂肪。本研究的目的是确定日本 RA 患者的肥胖和/或内脏脂肪与动脉粥样硬化风险之间的关系。采用 BMI 评估肥胖,采用内脏脂肪面积(VFA)和内脏/皮下脂肪比(V/S 比)评估内脏脂肪,采用双生物电阻抗法进行量化。通过颈动脉内膜中层厚度(IMT)和斑块评分(PS)评估动脉粥样硬化,通过超声进行测量。采用多变量分析确定与 IMT 和 PS 相关的因素。根据 BMI 和 VFA 水平将患者分组,比较各组间的 IMT 和 PS。RA 患者的 V/S 比高于健康对照组,校正年龄、BMI 和腰围后差异仍有统计学意义。多变量分析显示,V/S 比而非 BMI 与 IMT 和 PS 独立相关。在 BMI 和 VFA 的亚分类中,非肥胖且内脏脂肪含量高的患者(18.5≤BMI<25 kg/m2 且 VFA≥100 cm)的 IMT(平均 IMT,0.93±0.29 mm;最大 IMT,1.44±0.71 mm)和 PS(1.43±0.61)最高,与其他所有 BMI 和 VFA 亚组相比差异均有统计学意义。RA 患者内脏脂肪增加,与动脉粥样硬化斑块的高发生率相关。有内脏脂肪的非肥胖 RA 患者发生动脉粥样硬化的风险更高。